Abstract: Butterfly valve housing for a butterfly valve having a closing element mounted rotatably in the housing, wherein receiving openings are arranged in the housing between the two flange connection discs and between the reinforcement structure, wherein the receiving openings are directed from the outer circumference in the direction of the vertical centre axis, into which the inserts can be inserted into the housing, wherein the inserts are arranged form-fittingly in the receiving openings.

Abstract: Disclosure herein are an implantable cell containing device, its subcomponent scaffold, methods of making the same and their methods of use. The implantable cell containing device includes a scaffold and a cell-containing hydrogel encapsulating the scaffold. The scaffold has a tracheal-like internal system of continuous air-filled, hydrophobic micro-channels that traverse the scaffold's dimensions and a hydrophilic external surface. The implantable cell containing device, when implanted in a subject, can be used for delivering a therapeutic agent to a subject in need thereof for the treatment of various conditions and diseases.

Abstract: Butterfly valve housing for a butterfly valve having a closing element mounted rotatably in the housing, wherein receiving openings are arranged in the housing between the two flange connection discs and between the reinforcement structure, wherein the receiving openings are directed from the outer circumference in the direction of the vertical centre axis, into which the inserts can be inserted into the housing, wherein the inserts are arranged form-fittingly in the receiving openings.

Abstract: The present disclosure is directed to devices and systems for oxygenating encapsulated cells. The disclosure further relates to individual components of these devices and systems and methods of using the devices and systems to deliver a therapeutic agent to a subject in need thereof.

Abstract: Method for the preparation of moldings in a layer-by-layer process in which selectively areas of a powdered layer are melted, sintered, fused, or otherwise solidified, characterized in that as a powder for the powdered layer a thermoplastic, ground polyamide powder is used, in which the polyamide comprises laurolactam and caprolactam, preferably exclusively, and wherein the proportion of caprolactam is in the range of 40-60 mol % of the lactams used.

Abstract: A separating device for forming a standing area for livestock, in particular pigs, and for reducing emissions in pens, in particular in pig pens, comprises a base frame, a drainage element with a plurality of drainage channels which each comprise an outflow end, and shoulders, between which the plurality of drainage channels extends orthogonally to a drainage direction, a liquid-permeable endless belt with an upper run and a lower run, wherein the drainage element is arranged on the base frame such that a drainage direction of the plurality of drainage channels is directed in the direction of the outflow end.

Abstract: The present application relates cell replacement devices, comprising a frame cap and a frame base, where the frame cap includes a first connecting member and one or more ports that traverse a thickness of the frame cap. The frame base of the cell replacement device includes one or more walls defining an interior chamber, defining a first opening to the interior chamber on one side of the frame base, and defining a second opening to the interior chamber on another side of the frame base. The first opening of the frame base is configured to receive the frame cap, and the frame base further includes a second connecting member constructed to connect with the first connecting member. The frame base further comprises a mesh disposed adjacent the second opening.

Abstract: A separating device for forming a standing area for livestock, in particular pigs, and for reducing emissions in pens, in particular in pig pens, comprises a base frame, a drainage element with a plurality of drainage channels which each comprise an outflow end, and shoulders, between which the plurality of drainage channels extends orthogonally to a drainage direction, a liquid-permeable endless belt with an upper run and a lower run, wherein the drainage element is arranged on the base frame such that a drainage direction of the plurality of drainage channels is directed in the direction of the outflow end.

Abstract: A separating device for forming a standing area for livestock, in particular pigs, and for reducing emissions in pens, in particular in pig pens, comprises a base frame, a drainage element with a plurality of drainage channels which each comprise an outflow end, and shoulders, between which the plurality of drainage channels extends orthogonally to a drainage direction, a liquid-permeable endless belt with an upper run and a lower run, wherein the drainage element is arranged on the base frame such that a drainage direction of the plurality of drainage channels is directed in the direction of the outflow end.

Abstract: The present invention relates to an electrical actuating drive (1) for devices to be adjusted mechanically, having an electrical drive motor (2) and an output-drive shaft (4) which can be adjusted over a rotation actuating range of more than 360°, comprising an integrated contactless sensor angle measurement system (6) for determining and feeding back the respective rotation position of the output-drive shaft (4). The sensor angle measurement system (6) produces an output signal which largely simulates the characteristics of a conventional multiple potentiometer system.

Abstract: The present invention relates to an electrical actuating drive (1) for devices to be adjusted mechanically, having an electrical drive motor (2) and an output-drive shaft (4) which can be adjusted over a rotation actuating range of more than 360°, comprising an integrated contactless sensor angle measurement system (6) for determining and feeding back the respective rotation position of the output-drive shaft (4). The sensor angle measurement system (6) produces an output signal which largely simulates the characteristics of a conventional multiple potentiometer system.

Abstract: Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.

Abstract: Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, such as, e.g., stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.

Abstract: This invention relates to 2-heteroaryl-pyrimidine derivatives of general formula I or If as inhibitors of the cyclin-dependent kinases, their production as well as their use as medications for treating various diseases.

Abstract: Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.

Abstract: Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.

Abstract: Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.

Abstract: Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.

Abstract: Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.

Abstract: Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kaposi's sarcoma, restenosis, such as, e.g., stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, such as rheumatoid arthritis, hemangioma, angiofibroma; eye diseases, such as diabetic retinopathy, neovascular glaucoma; renal diseases, such as glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopathic syndrome, transplant rejections and glomerulopathy; fibrotic diseases, such as cirrhosis of the liver, mesangial cell proliferative diseases, arteriosclerosis, injuries to nerve tissue, and inhibition of the reocclusion of vessels after balloon catheter treatment, in vascular prosthetics or after mechanical devices are used to keep vessels open, such as, e.g.